Fig. 2
From: Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastoma
Validating the purity of hierarchical cluster labeling (A) Workflow outlines the sequential steps involved in the comparison of label purity in clinical and histopathological groups. (B) Heatmap showcasing the comprehensive array of Diagnosis variable among the PD/psPD patients with glioblastoma. (C) Mosaic plot compares cluster formation across the Diagnosis variable within the studied PD/psPD patient cohort by Fisher’s Exact Test. (D) Workflow of the performance and validation of the HC. (E) Boxplot showing silhouette and ARI metric. (F) Barplot showing RMSE, ARMSE, MAPE and CVIM metrics comparing Cohort A as a training and Cohort B as test and the inverse. (G) Distribution plot of the three clusters, showing the two most relevant principal component